(Q46675147)

24 December 2017

title

Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? (English)

1 reference

24 December 2017

main subject

chronic liver disease

0 references

author name string

Paul J Thuluvath

series ordinal

1

1 reference

24 December 2017

Karen L Krok

series ordinal

2

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

24 December 2017

The American Journal of Gastroenterology

published in

1 reference

24 December 2017

volume

100

1 reference

24 December 2017

issue

9

1 reference

24 December 2017

page(s)

1981-1983

1 reference

24 December 2017

Outcome of patients hospitalized for complications after outpatient liver biopsy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00284.X

10.1111/J.1572-0241.2005.00284.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017